MassMutual Private Wealth & Trust’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-107	Closed	–	–	1872
2022 Q2	$0	Sell	107 -2,298	-96%	-$10.9K	﹤0.01%	1777
2022 Q1	$18K	Hold	2,405	–	–	﹤0.01%	616
2021 Q4	$14K	Buy	2,405 +1,412	+142%	+$8.97K	﹤0.01%	665
2021 Q3	$6K	Hold	993	–	–	﹤0.01%	847
2021 Q2	$8K	Buy	993 +548	+123%	+$4.42K	﹤0.01%	742
2021 Q1	$5K	Hold	445	–	–	﹤0.01%	736
2020 Q4	$8K	Buy	+445	New	+$6.67K	﹤0.01%	642

Other funds holding PRVB

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MassMutual Private Wealth & Trust's PRVB Position: Q3 2022 in Review

MassMutual Private Wealth & Trust sold out of Provention Bio, Inc. Common Stock (PRVB) in Q3 2022, closing a stake of 107 shares.

MassMutual Private Wealth & Trust first reported a position in PRVB in Q4 2020 and held it in 7 quarters. The position peaked at $18K in Q1 2022. 112 funds tracked by Wall St. Rank hold PRVB as of Q3 2022.

MassMutual Private Wealth & Trust reported no remaining Provention Bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 107 Provention Bio, Inc. Common Stock shares in Q3 2022.
MassMutual Private Wealth & Trust first reported a position in Provention Bio, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
MassMutual Private Wealth & Trust's Provention Bio, Inc. Common Stock position peaked at $18K in Q1 2022.
112 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q3 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2022, filed 7 Oct 2022.